Stay updated on DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page.

Latest updates to the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page
- Check6 days agoChange DetectedThe site footer now identifies the platform as revision v3.8.0 instead of v3.7.2, while the study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedA banner announces an NIH website transition and says the agency is adopting “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check20 days agoChange DetectedThe site footer’s revision marker changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check27 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1; the study record page still displays a 403 error.SummaryDifference0.2%

- Check48 days agoChange DetectedRevision: v3.7.0 was added to the page, and a large set of MeSH terms and related keywords were removed from the study's metadata, affecting indexing terms but not the main study details.SummaryDifference19%

- Check69 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a backend or maintenance update to the record; no substantive study details appear to be affected.SummaryDifference0.1%

Stay in the know with updates to DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page.